Showing 21 - 40 results of 464 for search '"Multiple Sclerosis"', query time: 0.05s Refine Results
  1. 21
  2. 22

    Brugada Syndrome Caused by Autonomic Dysfunction in Multiple Sclerosis by Michel Ibrahim, Garly Saint-Croix, Rosario Colombo

    Published 2019-01-01
    “…Only one case report has previously described a patient with multiple sclerosis and a type 1 Brugada pattern on the electrocardiogram. …”
    Get full text
    Article
  3. 23
  4. 24
  5. 25

    Initial Immunopathogenesis of Multiple Sclerosis: Innate Immune Response by Norma Y. Hernández-Pedro, Guillermo Espinosa-Ramirez, Verónica Pérez de la Cruz, Benjamín Pineda, Julio Sotelo

    Published 2013-01-01
    “…Multiple sclerosis (MS) is an inflammatory, demyelinating, and neurodegenerative disease of the central nervous system. …”
    Get full text
    Article
  6. 26
  7. 27

    Myasthenia Gravis Development and Crisis Subsequent to Multiple Sclerosis by Kurosh Gharagozli, Maziar Shojaei, Ali Amini Harandi, Nayyereh Akbari, Manouchehr Ilkhani

    Published 2011-01-01
    “…During the last decade, sporadic combination of multiple sclerosis (MS) and myasthenia gravis (MG) has been reported repeatedly. …”
    Get full text
    Article
  8. 28
  9. 29
  10. 30

    Detection of opioid growth factor in Multiple Sclerosis Patients by Khamael Abdulla Taha, Mayada N. Iqbal, Gheyath Abd Ali Shalal

    Published 2020-12-01
    Subjects: “…Multiple sclerosis( MS) ; Opioid growth factor(OGF) ; body mass index(BMI)…”
    Get full text
    Article
  11. 31
  12. 32

    The Economic and Humanistic Burden of Pediatric-Onset Multiple Sclerosis by Nupur Greene, Lita Araujo, Cynthia Campos, Hannah Dalglish, Sarah Gibbs, Irina Yermilov

    Published 2022-10-01
    “…**Background:** Multiple sclerosis (MS) is a chronic inflammatory autoimmune disease of the central nervous system. …”
    Get full text
    Article
  13. 33
  14. 34
  15. 35

    Potential Application of Tregitopes as Immunomodulating Agents in Multiple Sclerosis by Wassim Elyaman, Samia J. Khoury, David W. Scott, Anne S. De Groot

    Published 2011-01-01
    “…Quantitative and qualitative defects of Tregs have been postulated to contribute to failed immune regulation in multiple sclerosis (MS) and other autoimmune diseases. This paper highlights the potential uses of T regulatory cell epitopes (Tregitopes), natural Treg epitopes found to be contained in human immunoglobulins, as immunomodulating agents in MS. …”
    Get full text
    Article
  16. 36

    Health-related quality of life in patients with multiple sclerosis by Lázaro Aurelio Vázquez Gómez, Carlos Hidalgo Mesa, Benita Mabel Beltrán González, Yunier Broche Pérez, Ana María Mederos Herrera

    Published 2022-02-01
    “…<p><strong>Background:</strong> multiple sclerosis is a disease characterized by outbreaks of disability in any functional system that are produced by inflammation and demyelination of the central nervous system.…”
    Get full text
    Article
  17. 37

    Restless Legs Syndrome as the Initial Presentation of Multiple Sclerosis by Ceyla Irkec, Doga Vurallı, Sebnem Karacay Ozkalaycı

    Published 2013-01-01
    “…There are several studies suggesting multiple sclerosis as one of the causes of symptomatic RLS. …”
    Get full text
    Article
  18. 38

    The Benefits and Detriments of Macrophages/Microglia in Models of Multiple Sclerosis by Khalil S. Rawji, V. Wee Yong

    Published 2013-01-01
    “…In three animal models of multiple sclerosis (MS), namely, experimental autoimmune encephalomyelitis (EAE) and cuprizone- and lysolecithin-induced demyelination, there have been many reported detrimental roles associated with the involvement of macrophages and microglia. …”
    Get full text
    Article
  19. 39
  20. 40